Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +55.89%
#3 DOVU DOVU +48.37%
#4 Velvet Velvet +44.60%
#5 Black Phoenix Black Phoenix +34.05%
#6 Cross Cross +27.56%
#7 Cap Cap +20.40%
#8 DoubleZero DoubleZero +17.42%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.92%
#10 Pieverse Pieverse +9.84%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Galera Therapeutics, Inc. Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
Rang in Aktien #33956
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.
Aktienkurs
$17.15
Zuletzt synchronisiert: 2026-08-03
Marktkapitalisierung
$6.51M
Veränderung (1 Tag)
9.80%
Veränderung (1 Jahr)
289.77%
Land
US
Handel Galera Therapeutics, Inc. (GRTX)

Kategorie

Healthcare
Kursverlauf für Galera Therapeutics, Inc. (GRTX)
Höchster Schlusskurs: $17.15 am 2026-08-01

Niedrigster Schlusskurs: $2.54K am 2019-11-01
Kursverlauf der Aktie von Galera Therapeutics, Inc. von 2019 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 98.59%
2025 -26.18%
2024 -76.56%
2023 -91.44%
2022 -45.34%
2021 -73.46%
2020 -7.59%
2019 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $733.26 7.36%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.99 13.97%
BE